Extending the duration of dual antiplatelet therapy: a clinical case study.

27 August 2017 (15:50 - 16:00)

Organised by:

About the speaker

Professor Dominick Joseph Angiolillo

University of Florida College of Medicine – Jacksonville, Jacksonville (United States of America)

3 More presentations in this session

Presentation thumbnail

Welcome and introduction - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Professor P. Steg (Paris, FR)

Presentation thumbnail

Open questions - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Professor P. Steg (Paris, FR) Professor D. Angiolillo (Jacksonville, US)

Presentation thumbnail

Session close - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Professor P. Steg (Paris, FR)

Access the full session

Session thumbnail

Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice (EBAC Accredited)

The Event

ESC Congress 2017

27 August 2017 15:50 CET

You may be interested in

Congress Presentation

When should prolonged antiplatelet regimens be considered?

26 August 2023

Webinar

Balancing stroke and bleeding risks in patients with AF and concomitant coronary artery disease, malignancy, chronic kidney disease, or frailty

10 November 2025

Congress Session

State-of-the-art antithrombotic treatment in acute coronary syndromes: a paradigm shift?

14 March 2025

Congress Presentation

Optimal strategy for antiplatelet therapy after coronary drug-eluting stent implantation in high-risk "TWILIGHT-like" patients with diabetes mellitus

17 April 2021

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources